Opzira, Inc. Launches to Advance Ophthalmic Diagnostics with Innovative Medical Device Portfolio

Creation of OpZira Inc. announced following Alcon's acquisition of LumiThera

OpZira Inc. launches innovative ophthalmic diagnostic tools, enhancing early detection and monitoring of ocular diseases for improved patient outcomes.

OpZira Launches With Goal of Advancing Ocular Disease Detection and Monitoring

Following Alcon’s acquisition of LumiThera, the maker of the Valeda Light Delivery System for the treatment of dry AMD, LumiThera’s diagnostic product lines were spun off to shareholders, forming the foundation of OpZira Inc. According to an OpZira news release, the company is dedicated to delivering technologies that enhance the detection and monitoring of ocular disease. OpZira enters the market with a portfolio of diagnostic technologies desi…